Crossref
Accelerating drug discovery process with genome editing technology from Tokushima
Folia Pharmacologica Japonica · 2023
DOI: 10.1254/fpj.23015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Folia Pharmacologica Japonica, 2023. Verfasst von Hiromi Takahashi. Beteiligte Einrichtung: SetsuroTech Inc. Hauptthemen laut MEDLINE: Gene Editing, CRISPR-Cas Systems. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Gene EditingCRISPR-Cas SystemsAnimalsMiceCRISPR-Associated Protein 9ElectroporationElectroporation Therapies
Substanzen
CRISPR-Associated Protein 9
Autor:innen und Institutionen
- SetsuroTech Inc.
Zitieren
APA
Takahashi, H. (2023). Accelerating drug discovery process with genome editing technology from Tokushima. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.23015
Vancouver
Takahashi H. Accelerating drug discovery process with genome editing technology from Tokushima. Folia Pharmacologica Japonica. 2023. doi:10.1254/fpj.23015
BibTeX
@article{Takahashi2023,
author = {Takahashi, Hiromi},
title = {Accelerating drug discovery process with genome editing technology from Tokushima},
journal = {Folia Pharmacologica Japonica},
year = {2023},
doi = {10.1254/fpj.23015}
}
EUVIMED